During its annual policy-making meeting, the American Medical Association (AMA) voted to adopt these new policies:
According to a first-ever report by the American Cancer Society in collaboration with the National Cancer Institute (NCI), the number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to approximately 18 million by 2022. The report, Cancer Treatment & Survivorship Facts & Figures, 2012-2013, and accompanying journal article published in CA: A Cancer Journal for Clinicians, used data from the NCI-funded Surveillance, Epidemiology, and End Results (SEER) program.
In an effort to address current cancer survivorship concerns, leading experts in the United States convened recently for the Cancer Survivorship Research Conference: Translating Science to Care, a conference jointly sponsored by the American Cancer Society’s Behavioral Research Center, the National Cancer Institute’s Office of Cancer Survivorship, the Lance Armstrong Foundation, and the Centers for Disease Control and Prevention.
A history of gum disease (periodontitis) may be associated with an increased risk of tumors positive for human papillomavirus (HPV) among patients with head and neck squamous cell carcinomas (SCC).
According to the National Cancer Institute, the incidence of oropharyngeal cancers has steadily increased in the United States since 1973, despite a significant decline in tobacco use since 1965. Study authors attribute the increase to oral HPV infection.
In a small study, a tiny light attached to a probe measured changes in cells and blood vessels in the small intestine close to that organ’s junction with the pancreas, allowing physicians at Mayo Clinic’s campus in Florida to detect pancreatic cancer 100% of the time. This minimally invasive technique, called Polarization Gating Spectroscopy, will now be tested in a much larger international clinical trial.
Research has shown that women who receive neoadjuvant chemotherapy are more likely to achieve breast conservation than those receiving chemotherapy after surgery. Therefore, women with breast cancer often undergo chemotherapy prior to surgery.
Now, a new study published online in the journal Radiology points to the fact that MRI provides an indication of a breast tumor’s response to presurgical chemotherapy significantly earlier than clinical examination.
Each year throughout the world, between 2 and 3 million nonmelanoma skin cancers develop, according to the World Health Organization. In the United States alone, it is estimated that 1 in 5 will develop the disease at some point in their lives.
Recently, researchers at the Society of Nuclear Medicine 2012 Annual Meeting announced that a customized patch treatment for basal cell carcinoma has been developed that entirely destroyed facial tumors without surgery or major radiation therapy in 80% of patients studied.
Previous studies suggest that taking nonsteroidal anti-inflammatory drugs (NSAIDs), which include aspirin, ibuprofen, and naproxen, as well as a variety of other nonprescription and prescription drugs, can decrease an individual’s risk of developing some types of cancer. New study findings, published early online in Cancer, indicate that these drugs may specifically protect patients from skin cancer.
With low participation rates in clinical trials, researchers are constantly seeking new methods to alter cancer patients’ perceptions and negative attitudes toward clinical trial involvement. In a recent study, researchers at Moffitt Cancer Center offered 2 different kinds of intervention to 2 groups of adults with cancer who had not yet been offered participation in clinical trials.
A majority of patients with incurable cancer talk with a physician about options for care at the end of life. Yet, according to a study by Dana-Farber Cancer Institute, this discussion often does not take place until late in the course of the illness.
To sign up for our newsletter or print publications, please enter your contact information below.
